VWM
TCON

Vigilare Wealth Management’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Vigilare Wealth Management’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-850
Closed -$110K – 222
2021
Q2 		$110K Buy
850
+150
+21% +$20.7K 0.07% 202
2021
Q1 		$115K Hold
700
– – 0.08% 191
2020
Q4 		$164K Sell
700
-150
-18% -$20.9K 0.16% 141
2020
Q3 		$88K Buy
+850
New +$45.5K 0.09% 135

Other funds holding TCON

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Vigilare Wealth Management's TCON Position: Q3 2021 in Review

Vigilare Wealth Management sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q3 2021, closing a stake of 850 shares — an estimated $110K sold.

Vigilare Wealth Management first reported a position in TCON in Q3 2020 and held it in 4 quarters. The position peaked at $164K in Q4 2020. 44 funds tracked by Wall St. Rank hold TCON as of Q3 2021.

  • Vigilare Wealth Management reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Vigilare Wealth Management sold 850 TRACON Pharmaceuticals, Inc. Common Stock shares in Q3 2021, an estimated $110K.
  • Vigilare Wealth Management first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
  • Vigilare Wealth Management's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $164K in Q4 2020.
  • 44 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on Vigilare Wealth Management's 13F filing for Q3 2021, filed 19 Oct 2021.